Serveur d'exploration SRAS - Analysis (France)

Index « AbsEn.i » - entrée « cov »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
course < cov < covdi  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 78.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000000 (2020-04-20) Henrik Salje [France] ; Cécile Tran Kiem [France] ; Noémie Lefrancq [France] ; Noémie Courtejoie [France] ; Paolo Bosetti [France] ; Juliette Paireau [France] ; Alessio Andronico [France] ; Nathanaël Hoze [France] ; Jehanne Richet [France] ; Claire-Lise Dubost [France] ; Yann Le Strat [France] ; Justin Lessler [États-Unis] ; Daniel Bruhl [France] ; Arnaud Fontanet [France] ; Lulla Opatowski [France] ; Pierre-Yves Boëlle [France] ; Simon Cauchemez [France]Estimating the burden of SARS-CoV-2 in France
000001 (2020-04-16) Etienne Joly [France]Confronting Covid-19 by exploring the possibility of vaccinating with live SARS- CoV-2 virus itself, via a route that would reduce the incidence of pulmonary complications
000008 (2020-03-12) Gustavo Cruz-Pacheco [Mexique] ; J. F. Bustamante-Casta Eda [Mexique] ; Jean-Guy Caputo [France] ; M. E. Jiménez-Corona ; S. Ponce-De-Le NDispersion of a new coronavirus SARS-CoV-2 by airlines in 2020: Temporal estimates of the outbreak in Mexico
000013 (2020) Adrien Breiman [France] ; Nathalie Ruvën-Clouet [France] ; Jacques Le Pendu [France]Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2
000014 (2020) Sylvie Van Der Werf [France] ; Cécile Peltekian [France]Émergence du coronavirus SARS-CoV-2 : faire face à l'épidémie de COVID-19.
000015 (2020) Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France]Type 1 interferons as a potential treatment against COVID-19
000016 (2020) B. Coutard [France] ; C. Valle [France] ; X. De Lamballerie [France] ; B. Canard [France] ; N. G. Seidah [Canada] ; E. Decroly [France]The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade
000017 (2020) Peter P. Liu [Canada] ; Alice Blet [France] ; David Smyth [Canada] ; Hongliang Li [République populaire de Chine]The Science Underlying COVID-19: Implications for the Cardiovascular System.
000018 (2020) Jean Christophe Lagier [France] ; Philippe Colson [France] ; Hervé Tissot Dupont [France] ; Jérôme Salomon [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Frédérique Gouriet [France] ; Sophie Baron [France] ; Pierre Dudouet [France] ; Rémi Flores [France] ; Lucie Ailhaud [France] ; Philippe Gautret [France] ; Philippe Parola [France] ; Bernard La Scola [France] ; Didier Raoult [France] ; Philippe Brouqui [France]Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?
000020 (2020) Alexandra C. Walls [États-Unis] ; Young-Jun Park [États-Unis] ; M. Alejandra Tortorici [États-Unis, France] ; Abigail Wall [États-Unis] ; Andrew T. Mcguire [États-Unis] ; David Veesler [États-Unis]Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
000021 (2020) Jacques Fantini [France] ; Coralie Di Scala [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.
000022 (2020) Lila Bouadma [France] ; Francois-Xavier Lescure [France] ; Jean-Christophe Lucet [France] ; Yazdan Yazdanpanah [France] ; Jean-Francois Timsit [France]Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists
000023 (2020) Yanis Roussel [France] ; Audrey Giraud-Gatineau [France] ; Marie-Thérèse Jimeno [France] ; Jean-Marc Rolain [France] ; Christine Zandotti [France] ; Philippe Colson [France] ; Didier Raoult [France]SARS-CoV-2: fear versus data
000024 (2020) Marco Alifano [France] ; Pietro Alifano [Italie] ; Patricia Forgez [France] ; Antonio Iannelli [France]Renin-angiotensin system at the heart of COVID-19 pandemic
000025 (2020) Ashleigh Shannon [France] ; Nhung Thi Tuyet Le [France] ; Barbara Selisko [France] ; Cecilia Eydoux [France] ; Karine Alvarez [France] ; Jean-Claude Guillemot [France] ; Etienne Decroly [France] ; Olve Peersen [États-Unis, France] ; Francois Ferron [France] ; Bruno Canard [France]Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
000026 (2020) Giuseppe Curigliano [Italie] ; Maria Joao Cardoso [Portugal] ; Philip Poortmans [France] ; Oreste Gentilini [Italie] ; Gabriella Pravettoni [Italie] ; Ketti Mazzocco [Italie] ; Nehmat Houssami [Australie] ; Olivia Pagani [Suisse] ; Elzbieta Senkus [Pologne] ; Fatima CardosoRecommendations for Triage, Prioritization and Treatment of Breast Cancer Patients During the COVID-19 Pandemic
000028 (2020) Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink [Pays-Bas] ; Stein Bergan [Norvège] ; Dirk Jan A R. Moes [Pays-Bas] ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France]Pharmacologic treatment of transplant recipients infected with SARS-CoV-2: considerations regarding therapeutic drug monitoring and drug-drug interactions.
000029 (2020) Franck Touret [France] ; Xavier De Lamballerie [France]Of chloroquine and COVID-19.
000030 (2020) Christian A. Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France]New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
000031 (2020) A. Bal [France] ; G. Destras [France] ; A. Gaymard [France] ; M. Bouscambert-Duchamp [France] ; M. Valette [France] ; V. Escuret [France] ; E. Frobert [France] ; G. Billaud [France] ; S. Trouillet-Assant [France] ; V. Cheynet [France] ; K. Brengel-Pesce [France] ; F. Morfin [France] ; B. Lina [France] ; L. Josset [France]Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del).
000032 (2020) Daniele De Luca [France]Managing neonates with respiratory failure due to SARS-CoV-2.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i -k "cov" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i  \
                -Sk "cov" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    cov
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021